Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16230137rdf:typepubmed:Citationlld:pubmed
pubmed-article:16230137lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:16230137lifeskim:mentionsumls-concept:C1457887lld:lifeskim
pubmed-article:16230137lifeskim:mentionsumls-concept:C1704272lld:lifeskim
pubmed-article:16230137lifeskim:mentionsumls-concept:C0426733lld:lifeskim
pubmed-article:16230137lifeskim:mentionsumls-concept:C0006050lld:lifeskim
pubmed-article:16230137lifeskim:mentionsumls-concept:C0332161lld:lifeskim
pubmed-article:16230137pubmed:issue4lld:pubmed
pubmed-article:16230137pubmed:dateCreated2005-10-18lld:pubmed
pubmed-article:16230137pubmed:abstractTextTo expand the clinical use of botulinum toxin A (BTX-A) in treating patients with small prostates and symptomatic benign prostatic hyperplasia (BPH). BTX-A injection into the prostate in patients with voiding dysfunction and large prostates has been reported.lld:pubmed
pubmed-article:16230137pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16230137pubmed:languageenglld:pubmed
pubmed-article:16230137pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16230137pubmed:citationSubsetIMlld:pubmed
pubmed-article:16230137pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16230137pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16230137pubmed:statusMEDLINElld:pubmed
pubmed-article:16230137pubmed:monthOctlld:pubmed
pubmed-article:16230137pubmed:issn1527-9995lld:pubmed
pubmed-article:16230137pubmed:authorpubmed-author:YoshimuraNaok...lld:pubmed
pubmed-article:16230137pubmed:authorpubmed-author:ChancellorMic...lld:pubmed
pubmed-article:16230137pubmed:authorpubmed-author:HuangChao-Che...lld:pubmed
pubmed-article:16230137pubmed:authorpubmed-author:ChuangYao-Chi...lld:pubmed
pubmed-article:16230137pubmed:authorpubmed-author:ChiangPo-HuiP...lld:pubmed
pubmed-article:16230137pubmed:issnTypeElectroniclld:pubmed
pubmed-article:16230137pubmed:volume66lld:pubmed
pubmed-article:16230137pubmed:ownerNLMlld:pubmed
pubmed-article:16230137pubmed:authorsCompleteYlld:pubmed
pubmed-article:16230137pubmed:pagination775-9lld:pubmed
pubmed-article:16230137pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:16230137pubmed:meshHeadingpubmed-meshheading:16230137...lld:pubmed
pubmed-article:16230137pubmed:meshHeadingpubmed-meshheading:16230137...lld:pubmed
pubmed-article:16230137pubmed:meshHeadingpubmed-meshheading:16230137...lld:pubmed
pubmed-article:16230137pubmed:meshHeadingpubmed-meshheading:16230137...lld:pubmed
pubmed-article:16230137pubmed:meshHeadingpubmed-meshheading:16230137...lld:pubmed
pubmed-article:16230137pubmed:meshHeadingpubmed-meshheading:16230137...lld:pubmed
pubmed-article:16230137pubmed:year2005lld:pubmed
pubmed-article:16230137pubmed:articleTitleBotulinum toxin type A improves benign prostatic hyperplasia symptoms in patients with small prostates.lld:pubmed
pubmed-article:16230137pubmed:affiliationDivision of Urology, Chang Gung Memorial Hospital, Kaohsiung, Taiwan.lld:pubmed
pubmed-article:16230137pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16230137lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16230137lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16230137lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16230137lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16230137lld:pubmed